The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study

Jonathan K. Wynn, Michael F. Green, Gerhard Hellemann, Kumari Karunaratne, Michael C. Davis, Stephen R. Marder

Research output: Contribution to journalLetterpeer-review

27 Scopus citations
Original languageEnglish
Pages (from-to)572-573
Number of pages2
JournalSchizophrenia Research
StatePublished - May 2018
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by grant 13T-003 from the Stanley Medical Research Institute (JKW and SRM, co-PIs), NIMH Grant R01 MH095878 (MFG, PI), and by a Department of Veterans Affairs Research Enhancement Program (MFG, PI). Theravalues Corporation (Tokyo, Japan) generously donated drug and matched placebo capsules. The funding agencies and Theravalues Corporation had no further role in the design, analysis, interpretation, or decision in publication of this study. For Michael C. Davis, participation occurred prior to his current position. The contents herein do not represent the views of the U.S. Department of Veterans Affairs, the U.S. Food and Drug Administration, or the United States Government.


  • BDNF
  • Cognition
  • Curcumin
  • Schizophrenia

Cite this